Edition:
United States

Joincare Pharmaceutical Group Industry Co Ltd (600380.SS)

600380.SS on Shanghai Stock Exchange

10.94CNY
24 May 2018
Change (% chg)

¥-0.03 (-0.27%)
Prev Close
¥10.97
Open
¥10.96
Day's High
¥11.03
Day's Low
¥10.89
Volume
8,593,256
Avg. Vol
23,909,603
52-wk High
¥13.99
52-wk Low
¥8.10

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical Group receives approval for drug clinical trial in U.S.
Friday, 18 May 2018 01:42am EDT 

May 18(Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says it received approval for drug clinical trial for Shenqi Fuzheng Injection, from U.S Food and Drug Administration .  Full Article

Joincare Pharmaceutical Group Industry to pay cash dividend of 1.8 yuan per 10 shares (before tax) for 2017
Monday, 2 Apr 2018 10:19pm EDT 

April 3(Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it plans to pay cash dividend of 1.8 yuan per 10 shares (before tax) to shareholders for 2017.  Full Article

Joincare Pharmaceutical's 2017 Net Profit Up 372.5 Percent Y/Y 2.1 Billion Yuan
Monday, 2 Apr 2018 05:43am EDT 

April 2 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>::SAYS 2017 NET PROFIT UP 372.5 PERCENT Y/Y 2.1 BILLION YUAN ($334.34 million).  Full Article

BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)
Wednesday, 7 Feb 2018 07:04am EST 

Corrects currency unit in headline and bullet point to yuan, not U.S. dollar:SAYS CAPITAL AT UNIT'S JV LIVZON BIOLOGICS WILL BE BOOSTED BY 600 MILLION YUAN ($94.94 million).  Full Article

Joincare Pharmaceutical Expects 2017 Net Profit To Rise 362.5-383.9 Percent Y/Y
Friday, 12 Jan 2018 03:04am EST 

Jan 12 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>::SAYS IT EXPECTS 2017 NET PROFIT TO RISE 362.5-383.9 PERCENT Y/Y VERSUS 451 MILLION YUAN ($69.67 million) YEAR AGO.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 04:13am EDT 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Joincare Pharmaceutical Group Industry unit receives approval for drug clinical trial
Friday, 3 Nov 2017 01:48am EDT 

Nov 3(Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says co's Zhuhai-based biotechnology unit received approval for drug clinical trial, regarding recombinant humanized anti-PD-1 monoclonal antibody for injection, from China Food and Drug Administration.  Full Article

Joincare Pharmaceutical Group Industry sees FY 2017 net profit up 337.2 pct to 370.3 pct
Friday, 27 Oct 2017 01:27am EDT 

Oct 27 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it sees net profit for FY 2017 to increase 337.2 percent to 370.3 percent, or to be 1.97 billion yuan to 2.12 billion yuan.Says the net profit of FY 2016 was 451.4 million yuan.Comments that sale of unit as main reason for the forecast .  Full Article

Joincare Pharmaceutical Group's 9-month net profit up 441.9 pct y/y
Thursday, 26 Oct 2017 07:17am EDT 

Oct 26 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says 9-month net profit up 441.9 percent y/y.  Full Article

Joincare Pharmaceutical Group Industry units get drug clinical trial approval for Tobramycin Inhalation Solution
Wednesday, 25 Oct 2017 02:47am EDT 

Oct 25 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS> ::Says its units and partners get drug clinical trial approval for Tobramycin Inhalation Solution.  Full Article